Mounjaro Logs 5.6 Billion Yen in Q3 YTD despite Curbed Shipments: Mitsubishi

Japan sales of Eli Lilly’s GIP/GLP-1 receptor agonist Mounjaro (tirzepatide) checked in at 5.6 billion yen on an NHI price basis in April-December last year, local distribution partner Mitsubishi Tanabe Pharma told Jiho on February 7. “While Mounjaro’s shipments are...read more